Qalsody (TOFERSEN) 6.7MG soln (2 vials) NDC: 64406-0109-01
Ended Awarded
- Contract number
- 36C26124N0750
- Awardee
-
Biogen U.s. Corporation UEI E82LHNZSCUA3
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,738
Award facts
- Contract value 100% obligated
- $21,738.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of QALSODY (TOFERSEN) 6.7MG SOLN (2 VIALS) NDC: 64406-0109-01 pharmaceutical product to the Department of Veterans Affairs (VA). The contract was awarded to Biogen U.S. Corporation, a subsidiary of Biogen Idec Incorporated, a biotechnology company focused on developing therapies for neurological diseases.
The contract is a firm-fixed-price delivery order valued at $21,738.30, awarded against Biogen's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The order was placed by the VA's Veterans Integrated Service Network 21, located in Cambridge, MA, with a completion date of August 2, 2024. This award is not set aside for any specific business type.
In addition to this delivery order, Biogen holds two other notable contract vehicles with the VA, including a single-award indefinite delivery contract worth up to $11.39 million for ranibizumab vials and syringes, and a Blanket Purchase Agreement valued at up to $430,578.10 for Spinraza, a drug used to treat spinal muscular atrophy. These contracts enable the VA to efficiently acquire necessary pharmaceuticals for veterans nationwide through December 2024.
Quick answers
Who was awarded contract 36C26124N0750?
36C26124N0750 was awarded to Biogen U.s. Corporation by Veterans Integrated Service Network 21 (Veterans Health Administration) on July 2, 2024.
How much is contract 36C26124N0750 worth?
The government has obligated $21,738 on 36C26124N0750.
Is contract 36C26124N0750 an order under another contract?
Yes. 36C26124N0750 is a delivery order under 36F79718D0566, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0750 competed?
The extent of competition for 36C26124N0750 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award